查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623528

全球蛋白质表现市场规模（按应用、产品、地区、范围和预测）

Global Protein Expression Market Size By Application (Therapeutic, Industrial), By Product (Reagents, Expression Vectors), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

蛋白质表现市场规模及预测

2021 年蛋白质表现市场价值为 28.7 亿美元，预计到 2030 年将达到 76.3 亿美元，2023 年至 2030 年的复合年增长率为 11.47%。该市场的成长主要得益于慢性病盛行率的上升、老年人口的增加以及对蛋白质生物製剂的需求的增加。新兴经济体可能为市场参与者提供巨大的成长机会。全球蛋白质表现市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球蛋白质表现市场

蛋白质表现是指生产特定蛋白质的生物技术过程，通常透过操纵生物体的基因表现使其表达大量重组基因来实现。基因工程和重组技术的发展为表达和分离异源蛋白质用于研究、临床和工业目的开闢了许多可能性。生物技术的重大进步使得大规模表达和分离重组蛋白成为可能。

一项重要成就是开发出可以进入细胞的重组蛋白。透过针对细胞内机製或以治疗性蛋白质取代细胞内操作酶，这些发展为治疗医学提供了全新的可能性。最先建立的表达平台是基于大肠桿菌的原核系统。此后，其他表现系统也得到了开发，包括昆虫、酵母、藻类和哺乳动物。蛋白质表现是指蛋白质在体内如何合成、修饰和调节。蛋白质表现在生物技术和製药行业的应用范围越来越广，主要受到私人和政府医疗机构的投资。

蛋白质表现的全球市场概况

蛋白质表现在研究、工业和治疗上有重要应用。治疗性蛋白质包括胜肽激素、疫苗、单株抗体、治疗性酵素、抗体、血液因子和细胞因子，广泛用于治疗癌症、糖尿病和多发性硬化症等慢性疾病。这些蛋白质正在提高生物製剂生产的品质、精确度和效率。

推动蛋白质表现市场成长的因素包括老年人口的增加、与年龄相关的疾病、癌症等慢性病盛行率的上升。此外，对蛋白质研究的支出增加也推动了蛋白质表现市场的成长。然而，与蛋白质产品生产相关的高资本投入限制了市场的成长。此外，训练有素的医疗专业人员严重短缺以及缺乏当地专业知识也限制了市场的发展。

质谱、分子遗传学和製造技术等技术创新的改进是蛋白质表现市场的主要驱动力。此外，新兴市场在疾病检测、医疗技术和医疗保健方面的快速发展应该会对市场产生积极影响。

目录

第 1 章全球蛋白质表现市场：简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章全球蛋白质表现市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 监理框架

第5章 全球蛋白质表现市场（按产品）

  • 概述
  • 试剂
  • 表达载体
  • 感受态细胞
  • 装置
  • 服务

第6章全球蛋白质表现市场（依应用）

  • 概述 治疗
  • 业
  • 研究

第7章全球蛋白质表现市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 世界其他地区

第 8 章全球蛋白质表现市场：竞争格局

  • 概述
  • 公司市占率
  • 供应商概况
  • 主要发展策略

第9章 公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Genscript Biotech Corporation
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Lonza Group Ltd.
  • New England Biolabs Inc.

第10章 附录

  • 关联报告
简介目录
Product Code: 24045

Protein Expression Market Size And Forecast

Protein Expression Market size was valued at USD 2.87 Billion in 2021 and is projected to reach USD 7.63 Billion by 2030 , growing at a CAGR of 11.47% from 2023 to 2030. The growth of this market is driven majorly by the rising incidence of chronic diseases, growth in the geriatric population, and rising demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. The Global Protein Expression Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Protein Expression Market Definition

Protein expression refers to a biotechnological process of generating specific proteins, typically attained by manipulating gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities for expressing and isolating heterogonous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled the expression & isolation of recombinant proteins on a large scale.

One of the significant achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to entirely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellular operating enzymes through therapeutic proteins. The first expression platform established was the prokaryotic system through Escherichia coli. The development of other expression systems, including insects, yeast, algae, and mammals followed this. Protein expression refers to how proteins are synthesized, modified, and regulated in living organisms. Protein expression is majorly being invested in by private and Govt. healthcare bodies due to the increasing scope of biotechnology and pharmaceutical industries.

Global Protein Expression Market Overview

Protein expression finds significant application in research, industrial and therapeutics, and others. Therapeutic proteins such as peptide hormones, vaccines, monoclonal antibodies, therapeutic enzymes, antibodies, blood factors, and cytokines are widely used to treat chronic diseases such as cancer, diabetes, and multiple sclerosis. These proteins have elevated quality, accuracy, and efficiency in biologics production.

The factors that boost the Protein Expression Market growth include an increase in the geriatric population, age-related diseases, and a rise in the prevalence of chronic diseases such as cancer. Moreover, increased spending on protein research also fuels the growth of the Protein Expression Market. However, high monetary inputs associated with the production of protein products restrict the market's growth. In addition, a significant shortage of trained healthcare professionals and a lack of local expertise also restrains the market.

Improvements in innovations such as mass spectrometry, molecular genetics, and manufacturing techniques are critical drivers in the Protein Expression Market. Furthermore, rapid developments in better disease detection, medical technology, and healthcare growth in emerging markets should positively impact the market.

Global Protein Expression Market: Segmentation Analysis

The Global Protein Expression Market is Segmented on the basis of Application, Product, And Geography.

Protein Expression Market, By Product

  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services

Based on Product, the market is bifurcated into Reagents, Expression vectors, competent cells, Instruments, and Services. The reagents segment was the largest revenue-grossing segment of the market due to the large application of these products for research and biopharmaceuticals manufacturing. The repetitive purchase of reagents for various applications including therapeutic, industrial, and research is expected to boost the market growth.

  • The services segment is anticipated to witness the fastest growth rate during the study period due to the escalating trend of services for custom optimization of protein expression. In addition, the service providers are equipped with advanced products and research specialists, which is expected to propel the demand for protein expression services by manufacturers and research laboratories.

Protein Expression Market, By Application

  • Therapeutic
  • Industrial
  • Research

Based on Application, the market is bifurcated into Therapeutic, Industrial, and Research. The therapeutic application segment dominated the overall sector in terms of revenue in 2016. This is due to the large application of protein expression for the production of biologics. These products provide high accuracy, efficiency, and quality in biologics production. This segment is also projected to grow at the highest rate during the forecast period owing to the growing popularity of therapeutic proteins over other drugs.

Protein Expression Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on regional analysis, the Global Flexible Substrates Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific market is expected to grow at the highest CAGR during the forecast period, owing to the rising penetration of contract research organizations and developing healthcare infrastructure in Asian countries including India and China. The availability of a massive genome pool, a large number of patients, accessibility of skilled personnel, and less stringent regulation for biologics production in Asian countries have propelled the sector growth in this region.

Key Players

  • The "Global Protein Expression Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Thermo Fisher Scientific Inc., Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Lonza Group Ltd., New England Biolabs Inc., Sengenics, Proteogenix, Synthetic Genomics Inc.
  • These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PROTEIN EXPRESSION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Reagents
  • 5.3 Expression Vectors
  • 5.4 Competent Cells
  • 5.5 Instruments
  • 5.6 Services

6 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Therapeutic
  • 6.3 Industrial
  • 6.4 Research

7 GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
  • 7.6 Rest of the World

8 GLOBAL PROTEIN EXPRESSION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Thermo Fisher Scientific Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Merck KGaA
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Genscript Biotech Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Agilent Technologies, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Takara Bio Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Promega Corporation
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Bio-Rad Laboratories, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Qiagen N.V.
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Lonza Group Ltd.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 New England Biolabs Inc.
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Reports